Evaluation of the PSMA-Binding Ligand (212)Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer

Radioligand therapy targeting the prostate-specific membrane antigen (PSMA) is rapidly evolving as a promising treatment for metastatic castration-resistant prostate cancer. The PSMA-targeting ligand p-SCN-Bn-TCMC-PSMA (NG001) labelled with (212)Pb efficiently targets PSMA-positive cells in vitro an...

Descripción completa

Detalles Bibliográficos
Autores principales: Stenberg, Vilde Yuli, Larsen, Roy Hartvig, Ma, Li-Wei, Peng, Qian, Juzenas, Petras, Bruland, Øyvind Sverre, Juzeniene, Asta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124365/
https://www.ncbi.nlm.nih.gov/pubmed/34062920
http://dx.doi.org/10.3390/ijms22094815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124365/
https://www.ncbi.nlm.nih.gov/pubmed/34062920
http://dx.doi.org/10.3390/ijms22094815

Ejemplares similares